| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 37 |
| 1 | ARIPIPRAZOLE ORAL | 35 |
| 2 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 35 |
| 3 | CERTOLIZUMAB PEGOL | 17 |
| 4 | LEVETIRACETAM | 15 |
| 5 | LEVETIRACETAM IN SODIUM CHLORIDE | 13 |
| 6 | LEVETIRACETAM INJECTION | 13 |
| 7 | LEVETIRACETAM ORAL | 13 |
| 8 | ETONOGESTREL | 12 |
| 9 | LEVONORGESTREL | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZURANOLONE | 4 | 0.0021 |
| 1 | BETAXOLOL HYDROCHLORIDE | 1 | 0.0019 |
| 2 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| 3 | BEROTRALSTAT HYDROCHLORIDE | 1 | 0.0011 |
| 4 | NORGESTREL | 1 | 0.0007 |
| 5 | NARATRIPTAN | 1 | 0.0007 |
| 6 | ECALLANTIDE | 1 | 0.0005 |
| 7 | BRIVARACETAM | 3 | 0.0003 |
| 8 | CARIPRAZINE | 3 | 0.0003 |
| 9 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 46 |
| 1 | Progestin [EPC] | 25 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 24 |
| 3 | Corticosteroid [EPC] | 15 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 5 | Progestin-containing Intrauterine System [EPC] | 12 |
| 6 | Anti-epileptic Agent [EPC] | 7 |
| 7 | Integrin Receptor Antagonist [EPC] | 7 |
| 8 | Mood Stabilizer [EPC] | 6 |
| 9 | Provitamin D2 Compound [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] | 4 | 0.0021 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 2 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 4 | Progesterone [EPC] | 5 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 6 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Influenza A M2 Protein Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 9 | Leukotriene Receptor Antagonist [EPC] | 3 | 0.0001 |